The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders

被引：67
作者：
Wu, Kuo-Chen [1 ]
Lin, Chun-Jung [1 ]
机构：
[1] Natl Taiwan Univ, Sch Pharm, 33 Linsen South Rd, Taipei 100, Taiwan
来源：
JOURNAL OF FOOD AND DRUG ANALYSIS | 2019年 / 27卷 / 01期
关键词：
Drug-metabolizing enzyme; Inflammation; Membrane transporter; Pharmacokinetics; PREGNANE-X-RECEPTOR; NF-KAPPA-B; CONSTITUTIVE ANDROSTANE RECEPTOR; P-GLYCOPROTEIN EXPRESSION; BLOOD-BRAIN-BARRIER; ADJUVANT-INDUCED ARTHRITIS; MESSENGER-RNA EXPRESSION; MDR1; GENE-EXPRESSION; HEPATIC CYTOCHROME-P450; GLUCOCORTICOID-RECEPTOR;
D O I：
10.1016/j.jfda.2018.11.005
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
Drug-metabolizing enzymes (DMEs) and membrane transporters play important roles in the absorption, distribution, metabolism, and excretion processes that determine the pharmacokinetics of drugs. Inflammation has been shown to regulate the expression and function of these drug-processing proteins. Given that inflammation is a common feature of many diseases, in this review, the general mechanisms for inflammation-mediated regulation of DMEs and transporters are described. Also, evidences regarding the aberrant expression of these drug-processing proteins in several inflammatory diseases and age-related disorders are provided. Copyright (C) 2018, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
引用
收藏
页码：48 / 59
页数：12
相关论文
共 114 条
[41]   Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia [J].
Hartmann, G ;
Cheung, AKY ;
Piquette-Miller, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (01) :273-281
[42]   P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy [J].
Hartz, Anika M. S. ;
Pekcec, Anton ;
Soldner, Emma L. B. ;
Zhong, Yu ;
Schlichtiger, Juli ;
Bauer, Bjoern .
MOLECULAR PHARMACEUTICS, 2017, 14 (04) :999-1011
[43]   Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease [J].
Hartz, Anika M. S. ;
Miller, David S. ;
Bauer, Bjoern .
MOLECULAR PHARMACOLOGY, 2010, 77 (05) :715-723
[44]   The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene [J].
Honkakoski, P ;
Zelko, I ;
Sueyoshi, T ;
Negishi, M .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (10) :5652-5658
[45]   Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells [J].
Hukkanen, J ;
Väisänen, T ;
Lassila, A ;
Piipari, R ;
Anttila, S ;
Pelkonen, O ;
Raunio, H ;
Hakkola, J .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (02) :745-752
[46]   HEPATIC CYTOCHROME-P-4503A (CYP3A) ACTIVITY IN THE ELDERLY [J].
HUNT, CM ;
WESTERKAM, WR ;
STAVE, GM ;
WILSON, JAP .
MECHANISMS OF AGEING AND DEVELOPMENT, 1992, 64 (1-2) :189-199
[47]   LXRs AND FXR: The Yin and Yang of cholesterol and fat metabolism [J].
Kalaany, NY ;
Mangelsdorf, DJ .
ANNUAL REVIEW OF PHYSIOLOGY, 2006, 68 :159-191
[48]   Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats [J].
Kalitsky-Szirtes, J ;
Shayeganpour, A ;
Brocks, DR ;
Piquette-Miller, M .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (01) :20-27
[49]   Role of human hepatocyte nuclear factor 4α in the expression of drug-metabolizing enzymes and transporters in human Hepatocytes assessed by use of small interfering RNA [J].
Kamiyama, Yoshiteru ;
Matsubara, Tsutomu ;
Yoshinari, Kouichi ;
Nagata, Kiyoshi ;
Kamimura, Hidetaka ;
Yamazoe, Yasushi .
DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (04) :287-298
[50]   Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone [J].
Kao, Yu-Han ;
Chern, Yijuang ;
Yang, Hui-Ting ;
Chen, Hui-Mei ;
Lin, Chun-Jung .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (08) :1412-1423
12345678910